Imalux Collaborates with Preventative Oncology International™ in Study of Cervical Cancer in China
Dr. Jerome Belinson, a leading researcher ingynecological cancers, and his team from Preventative Oncology International™ (POI),along with Dr. Nancy Tresser, Chief Medical Officer of Imalux Corporation, recentlycollaborated in a controlled 299 patient study of cervical cancer in China.Cervical cancer is the second greatest cause of cancer deaths in women world-wide. It isdirectly linked to the high-risk types of the Human Papillomavirus (HPV). While the currentstandard for cervical cancer diagnosis in the US is based upon the Pap test, the link betweencervical cancer and HPV has made it possible to identify patients at high risk of cervicalcancer by testing ...
Login to comment.